Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
17-OHPC Concentration and Preterm Birth
NCT03292731Phase 2Terminated
- Start
- Feb 2018
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of hydroxyprogesterone caproate in preterm birth. Started Feb 2018; status: terminated.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT03292731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03292731.